Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy

被引：4

作者：

Pinto, Valeria ^{[1
]}

Balocco, Manuela ^{[1
]}

Ambaglio, Ilaria ^{[2
]}

Derchi, Giorgio ^{[3
]}

Malcovati, Luca ^{[2
]}

Forni, Gian Luca ^{[1
]}

机构：

[1] Osped Galliera, Ematol Ctr Microcitemia & Anemie Congenite, Via Volta 6, I-16128 Genoa, Italy

[2] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Dept Hematol Oncol, I-27100 Pavia, Italy

[3] Osped Galliera, Unit Cardiol, Genoa, Italy

来源：

CLINICAL CASE REPORTS | 2015年 / 3卷 / 11期

关键词：

Deferiprone; desferal; heart failure; iron chelation; myelodysplastic syndromes;

D O I：

10.1002/ccr3.407

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Key Clinical Message Patients with transfusion-dependent myelodysplastic syndromes (MDS) have an increased risk of cardiac events, due to both chronic anemia and iron overload. Here, we report the recovery of cardiac function after an intensive iron chelation therapy in a MDS patient who had developed heart failure due to iron overload.

引用

页码：952 / 954

页数：3

共 50 条

[41] Iron Chelation in Transfusion-Dependent Patients With Low-to Intermediate-1-Risk Myelodysplastic Syndromes RESPONSE
Angelucci, Emanuele
Greenberg, Peter
Izquierdo, Miguel
Garcia-Manero, Guillermo
ANNALS OF INTERNAL MEDICINE, 2020, 173 (07) : 595 - 596
[42] Cost-effectiveness analysis of oral iron chelation therapy with deferasirox (Exjade®, ICL670) versus infusional chelation therapy with deferoxamine in patients with transfusion-dependent myelodysplastic
Delea, TE
Thomas, SK
Baladi, JF
Phatak, PD
BLOOD, 2005, 106 (11) : 484B - 485B
[43] Iron chelation therapy in transfusion dependent patients with myelodysplastic syndrome with transfusional iron-overload in routine clinical management - interim analysis of the non-interventional study EXSEPT
Nolte, F.
Rubanov, O.
Kuehn, R-B
Schumann, C.
Kreil, S.
Metzgeroth, G.
Junkes, A.
Johr, C.
Albrecht, S.
Hofmann, W-K
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 251 - 251
[44] Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review
Delea, Thomas E.
Edelsberg, John
Sofrygin, Oleg
Thomas, Simu K.
Baladi, Jean-Francois
Phatak, Pradyumna D.
Coates, Thomas D.
TRANSFUSION, 2007, 47 (10) : 1919 - 1929
[45] Getting the iron out: Preventing and treating heart failure in transfusion-dependent thalassemia
Jabbar, Danish A.
Davison, Glenn
Muslin, Anthony J.
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2007, 74 (11) : 807 - +
[46] Therapeutic mechanism of combined oral chelation therapy to maximize efficacy of iron removal in transfusion-dependent thalassemia major - a pilot study
Lin, Chien-Heng
Chen, Xianxiu
Wu, Chin-Ching
Wu, Kang-Hsi
Song, Ta-Shu
Weng, Te-Fu
Hsieh, Yow-Wen
Peng, Ching-Tien
EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (04) : 265 - 272
[47] Quality of life (QoL) and symptoms in transfusion-dependent patients with myelodysplastic syndromes (MDS) undergoing oral chelation therapy
Efficace, Fabio
Cottone, Francesco
Vignetti, Marco
Mandelli, Franco
Angelucci, Emanuele
QUALITY OF LIFE RESEARCH, 2013, 22
[48] Rapid iron loading in a pregnant woman with transfusion-dependent thalassemia after brief cessation of iron chelation therapy
Farmaki, Kallistheni
Gotsis, Efstathios
Tzoumari, Ioanna
Berdoukas, Vasilios
EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (02) : 157 - 159
[49] IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROMES AND IN OTHER TRANSFUSION-DEPENDENT CHRONIC ANEMIAS. RETROSPECTIVE STUDY OF 69 PATIENTS FROM A SINGLE INSTITUTION
Finelli, C.
Clissa, C.
Barraco, M.
De Maio, C.
Stanzani, M.
Parisi, S.
Paolini, S.
Bosi, C.
Cavo, M.
HAEMATOLOGICA, 2017, 102 : 770 - 771
[50] The impact of chelation therapy on survival in transfusional iron overload: a meta-analysis of myelodysplastic syndrome
Mainous, Arch G., III
Tanner, Rebecca J.
Hulihan, Mary M.
Amaya, Mirna
Coates, Thomas D.
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (05) : 720 - 723

← 1 2 3 4 5 →